is unsuitable for systemic therapy. Polymyxin is less toxic and may be given systemically if used with caution, but is however liable to produce neurotoxic side-effects (Kagan and others, 1951) . As there is now such a wide choice of antibiotics, it is good practice to use those which are toxic when given systemically for topical application wherever possible, reserving those more suitable for systemic therapy for this purpose. Susceptible organisms rarely develop resistance to polymyxin either in vivo or in vitro (Jawetz and Coleman, 1949; Pulaski and others, 1949) . Bacterial resistance to bacitracin can be increased in vitro by successive subculture of the org'anism in media containing sublethal concentrations of the antibiotic, but resistance is developed with difficulty (Gezon and others, 1950) .
Ointment containing bacitracin and polymyxin has been used in the treatment of skin infections. Kile and others (1953) reported 459 cases, most of which responded well to the treatment. They used ointment consisting of 400 units bacitracin and 10,000 units polymyxin " B " per gramme of petrolatum. This anhydrous base ensui-ed stability. An identical ointment was used in the trials described below. In each case the ointment was applied to a groove in an agar plate seeded with test organisms all originally cultured from eye infections. The three plates were inoculated at the same time from broth cultures of the various organisms. The photographs were taken after 24 hrs' incubation at 39°C. The complementary nature of the two antibiotics is well shown in Fig. 3 ; the mixture is seen to inhibit the growth of both Gram-positive and Gram-negative organisms.
EXPERIMENTAL PS. PYOCYANEUS INFECTION OF THE CORNEA.-The value of polymyxin given by subconjunctival injection in the treatment of established Ps. pyocyaneus infection of the cornea, both experimentally induced and occurring in clinical practice, has already been demonstrated (Ainslie and Smith, 1952; Ainslie, 1953) .
The local application of an ointment to the conjunctival sac could not be expected to cure established infection due to so virulent an organism. It was, however, decided to assess its efficacy as a prophylactic againlst the infection of corneal abrasions.
A circular area 5 mm. in diameter in the centre of the right cornea of each of forty rabbits was scarified, and a drop from a 24-hr broth culutre of Ps. pyocyaneus was applied to the wound. In 23 cases polymyxin-bacitracin ointment was then instilled into the conjunctival sac and the lids were closed. The ointment was reapplied three times daily for 3 days. In seventeen rabbits no treatment was given. In sixteen of the untreated cases, infection became established and progressed rapidly to involve the whole cornea in from 24 to 48 hours. Of the treated cases fifteen remained uninfected, slight infection which cleared within 3 days occurred in six, and in two infection was severe and continued to progress despite treatment. CLINICAL TRIALS Blepharitis.-In 33 cases of ulcerative blepharitis, bacitracin-polymyxin ointment was applied to the lids four times daily for the first week of treatment and then twice daily for a further 2 to 3 weeks. In addition, saline lotion was used to help in the removal of crusts and discharge from the lid margins.
EXPERIMENTAL STAPHYLOCOCCUS
In 24 patients symptoms and signs disappeared completely. They have remained symptom-free for from 3 to 6 months without further treatment.
In six cases recurrence followed the cessation of treatment but further treatment has kept the condition under control. One case improved initially and then relapsed, and further therapy brought no benefit. Two cases did not respond at all. Before treatment was started cultures were taken from the lid margins in each case. Staphylococcus aureus was grown from seventeen cases, KochWeeks bacillus from three, Staphyloccus albus from three, B. xerosis from three, and B. coli from one; no growth was obtained in six instances. Of the two cases which failed to improve, one had produced a growth of Staph. aureus and one had produced no growth. The persistently recurrent case had produced a growth of B. xerosis only. Of the six other cases which recurred but nevertheless responded to further treatment, four had given a growth of Staph. aureus, one of B. xerosis, and the other no growth.
Corneal Ulceration.-Twenty cases of non-specific corneal ulceration were treated with bacitracin-polymyxin ointment applied twice daily, and in addition atropine drops were instilied daily in all but two cases. Healing occurred rapidly in every case, the period of treatment required being from 3 to 8 days. No ulcers of specific aetiology such as dendritic ulcers were included in this series.
Corneal Injury.-In 123 cases of corneal injury due to embedded foreign body (88 cases) and abrasions (35 cases) the ointment was used as a prophylaxis against infection. An application to the conjunctival sac was made at the patient's first attendance. Twice daily applications were made until healing was complete, which took from 1 to 8 days. In the more severe cases atropine drops were applied in addition.
Of the 123 cases so treated, 115 healed uneventfully; in eight a moderate degree of corneal infiltration occurred but settled within a few days; in the remaining five infiltration was more severe and carbolization was required. After this procedure and continuous treatment with the ointment healing was rapid. Nebula formation was minimal in all cases.
In the total number of cases treated (176) there was no allergic response, though in nine instances the patients complained of slight irritation after applying the ointment. Five of the cases of blepharitis treated had given a history of an allergic response to previous treatments but showed no such response when treated with polymyxin and bacitracin.
